AbbVie paid its 5 named executives $81.0M in total in FY2025 (Dec). CEO Robert A. Michael was paid $32.5M of that.
PayNo stock prices for these years
Pay of each named executive
Robert A. MichaelChief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) | ||||||
| FY2019 (Dec) | ||||||
| FY2018 (Dec) |
7 years
Jeffrey R. StewartExecutive Vice President, Chief Commercial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Scott T. ReentsExecutive Vice President, Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Azita Saleki-GerhardtExecutive Vice President, Chief Operations Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Roopal B. ThakkarExecutive Vice President, Research & Development and Chief Scientific Officer
| FY2025 (Dec) |
1 year
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $27.6M. The CEO of AbbVie was paid $32.5M, 18% above the median.
- 1Eli Lilly & Co
- 2Johnson & Johnson
- 3AbbVieThis company
- 4Gilead Sciences
- 5Pfizer
- 6Amgen
- 7Bristol Myers Squibb
- 8Merck & Co.
- 9GlaxoSmithKline plcNot disclosed
- 10Novartis AGNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.